Article info

Extended report
Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice

Authors

  1. Correspondence to Vivian Bykerk, Inflammatory Arthritis Center, Hospital for Special Surgery, New York, New York, 10021, USA; USA; bykerkv{at}hss.edu
View Full Text

Citation

Bykerk VP, Östör AJK, Alvaro-Gracia J, et al
Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice

Publication history

  • Accepted March 23, 2012
  • First published May 21, 2012.
Online issue publication 
November 02, 2012

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

    • Web Only Data - This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.